Vinay Rajani of HDFC Securities says Divis Labs share price has broken out from the box pattern on the daily chart with the ...
Amid the rising volatility in the Indian equity markets, domestic brokerage firm BP Equities has shared its top picks for ...
Citi said it believes Divi's Laboratories' revenue and earnings before interest, tax, depreciation, and amortisation (EBITDA) ...
NDTV Profit on MSN
Five Stocks To Buy: Divi's Labs, Aurobindo Pharma, Britannia And More
Multiple experts are converging on select pharma, FMCG, media, and financial services counters. Key names on today’s radar ...
Nifty Pharma index closed up 1.69% at 23126.85 today. The index has gained 1.00% over last one month. Among the constituents, Divis Laboratories Ltd added 4.38%, Ipca Laboratories Ltd rose 4.01% and ...
Divi's Laboratories Limited is an India-based company, which is engaged in pharmaceutical ingredients (APIs), intermediates and nutraceutical ingredients with predominance in exports. The Company’s ...
Divi’s Laboratories shares gained over 3 per cent as analysts flagged 2026 as a potential inflection point, driven by a ...
Here are some of the stocks that may see significant price movement today: Biocon Limited, Tata Capital, Godrej Consumer, etc ...
Mahindra is ready to pull the wraps off the XUV 7XO on January 5, 2026. Positioned as a tech-heavy evolution of the XUV700, ...
TipRanks on MSN
Divi’s Laboratories files SEBI dematerialisation compliance certificate for December quarter
An update from Divi’s Laboratories Limited ( ($IN:DIVISLAB) ) is now available. Divi’s Laboratories Limited has submitted to the National Stock ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results